Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-07 · accession 0001649094-24-000105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-11-08 | 2024-11-07 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $103.89 | -2,366 | 137.4K | -2% | -$245.8K |
| DM | 2024-11-08 | 2024-11-07 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $3.71 | +30.8K | 466.0K | +7% | +$114.3K |
| DM | 2024-11-08 | 2024-11-07 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -30.8K | 0 | -100% | $0 |
| DM | 2024-11-08 | 2024-11-07 | PCVX | PICKERING GRANT | CEO, Dir | A - Grant | $0.00 | +278.4K | 197.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | S | D | 227 | $102.68 | 138,354 | I By Children's Trust | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $102.19 to $103.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Shares are held directly by a trust for the benefit of the Reporting Person's daughter. |
| 2 | Common | Common Stock | 2024-11-07 | S | D | 434 | $104.72 | 137,503 | I By Children's Trust | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $104.405 to $105.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F7) Shares are held directly by a trust for the benefit of the Reporting Person's son. |
| 3 | Common | Common Stock | 2024-11-07 | S | D | 363 | $103.36 | 137,937 | I By Children's Trust | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $103.28 to $104.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F7) Shares are held directly by a trust for the benefit of the Reporting Person's son. |
| 4 | Common | Common Stock | 2024-11-07 | S | D | 281 | $102.64 | 138,300 | I By Children's Trust | — | — | (F6) The price reported is a weighted-average price. The shares were sold at prices ranging from $102.09 to $103.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F7) Shares are held directly by a trust for the benefit of the Reporting Person's son. |
| 5 | Common | Common Stock | 2024-11-07 | S | D | 116 | $105.50 | 137,398 | I By Children's Trust | — | — | (F3) Shares are held directly by a trust for the benefit of the Reporting Person's daughter. |
| 6 | Common | Common Stock | 2024-11-07 | S | D | 377 | $104.71 | 137,514 | I By Children's Trust | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $104.405 to $105.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Shares are held directly by a trust for the benefit of the Reporting Person's daughter. |
| 7 | Common | Common Stock | 2024-11-07 | S | D | 463 | $103.43 | 137,891 | I By Children's Trust | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $103.28 to $104.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Shares are held directly by a trust for the benefit of the Reporting Person's daughter. |
| 8 | Common | Common Stock | 2024-11-07 | M | A | 663 | $0.04 | 435,882 | D | — | — | |
| 9 | Common | Common Stock | 2024-11-07 | M | A | 14,129 | $2.03 | 450,011 | D | — | — | |
| 10 | Common | Common Stock | 2024-11-07 | S | D | 105 | $105.50 | 137,398 | I By Children's Trust | — | — | (F7) Shares are held directly by a trust for the benefit of the Reporting Person's son. |
| 11 | Common | Common Stock | 2024-11-07 | M | A | 16,000 | $5.35 | 466,011 | D | — | — | |
| 12 | Derivative | Stock Option (right to buy) | 2024-11-07 | M | D | 16,000 | $0.00 | 202,717 | D | $5.35 · — to 2030-04-17 | 16,000 Common Stock | (F8) Stock Option is fully vested and exercisable. |
| 13 | Derivative | Performance Restricted Stock Units | 2024-11-07 | A | A | 80,625 | $0.00 | 80,625 | D | $0.00 · — to 2034-11-06 | 80,625 Common Stock | (F10) Represents the target number of shares of Issuer's Common Stock underlying an award of performance restricted stock units ("PSUs"). Each PSU represents the contingent right to receive one share of the Issuer's Common Stock. The attainment of the performance vesting condition will be based on the Issuer's percentile rank within a peer group based on total shareholder return ("TSR") during a four-year performance period that commenced on November 7, 2024, the Grant Date, subject to the Reporting Person's continuous service with the Issuer through completion of the performance period. The actual number of shares of the Issuer's Common Stock deliverable with respect to the award varies based on performance and ranges from 0% to 250% of the target number of shares. |
| 14 | Derivative | Performance Stock Option (right to buy) | 2024-11-07 | A | A | 197,784 | $0.00 | 197,784 | D | $102.70 · — to 2034-11-06 | 197,784 Common Stock | (F9) As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the "Grant Date"), the Reporting Person was granted a performance stock option to purchase 197,784 shares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth and fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price)). |
| 15 | Derivative | Stock Option (right to buy) | 2024-11-07 | M | D | 14,129 | $0.00 | 153,198 | D | $2.03 · — to 2028-07-23 | 14,129 Common Stock | (F8) Stock Option is fully vested and exercisable. |
| 16 | Derivative | Stock Option (right to buy) | 2024-11-07 | M | D | 663 | $0.00 | 0 | D | $0.04 · — to 2025-04-23 | 663 Common Stock | (F8) Stock Option is fully vested and exercisable. |